華通醫藥(002758.SZ):證券簡稱擬變更為“浙農股份”
格隆匯 12 月 2日丨華通醫藥(002758.SZ)公佈,公司重大資產重組完成後主營業務發生變更,為使公司名稱與公司主營業務更相匹配,更能體現公司發展戰略,公司擬將中文名稱由“浙江華通醫藥股份有限公司”變更為“浙農集團股份有限公司”,英文名稱由“Zhejiang Huatong Pharmaceutical Co.,Ltd.”變更為“ZJAMP Group Co., Ltd.” (以市場監督管理部門最終核准的公司名稱為準),公司證券簡稱由“華通醫藥”變更為“浙農股份”。
此次重組前,公司的主營業務為藥品批發、藥品零售、藥品生產銷售。此次重組後,公司將轉型成為主營產品涵蓋農資、汽車,同時經營醫藥,服務城鄉人民生產生活綜合平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.